110 related articles for article (PubMed ID: 3133776)
1. Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF).
Nilsson IM
Semin Hematol; 1988 Apr; 25(2 Suppl 1):33-7. PubMed ID: 3133776
[No Abstract] [Full Text] [Related]
2. Ultracentrifugal analysis of factor VIII and von Willebrand factor in therapeutic preparations.
Aronson DL; Chang P
Vox Sang; 1995; 69(1):8-13. PubMed ID: 7483501
[TBL] [Abstract][Full Text] [Related]
3. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
[TBL] [Abstract][Full Text] [Related]
4. [Production of factor VIII deficient plasma by immunodepletion using monoclonal antibodies to vWF and to factor VIII, and its application].
Nakai H; Shima M; Tanaka I; Fujiwara T; Terada S; Takase T; Yoshioka A; Fukui H
Rinsho Byori; 1988 Apr; 36(4):475-80. PubMed ID: 3136264
[No Abstract] [Full Text] [Related]
5. Factor VIII/von Willebrand factor.
Fukui H
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1510-8. PubMed ID: 2451878
[No Abstract] [Full Text] [Related]
6. Immunoaffinity purification of factor VIII complex.
Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor].
Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
C R Seances Acad Sci III; 1981 May; 292(18):1055-7. PubMed ID: 6790137
[TBL] [Abstract][Full Text] [Related]
8. Human Factor VIII:C purified using monoclonal antibody to von Willebrand factor. Proceedings from a satellite symposium, XIth International Congress on Thrombosis and Haemostasis. July 11, 1987, Brussels.
Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-45. PubMed ID: 3133771
[No Abstract] [Full Text] [Related]
9. The separation of Willebrand factor from factor VIII-related antigen.
Barrow ES; Reisner HM; Graham JB
Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
[TBL] [Abstract][Full Text] [Related]
11. Purification of factor VIII by monoclonal antibody affinity chromatography.
Zimmerman TS
Semin Hematol; 1988 Apr; 25(2 Suppl 1):25-6. PubMed ID: 3133773
[No Abstract] [Full Text] [Related]
12. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
Johnson AJ; Macdonald VE; Brind J
Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
[TBL] [Abstract][Full Text] [Related]
13. Purification of human factor VIII from a heat-treated factor VIII concentrate in the presence of potent protease inhibitors.
Shima M; Yoshioka A; Tanaka I; Fujiwara T; Nakai H; Tsubura Y; Fukui H
Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1239-45. PubMed ID: 3120453
[No Abstract] [Full Text] [Related]
14. Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.
Levine PH
Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-2. PubMed ID: 3133770
[No Abstract] [Full Text] [Related]
15. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
Proc Natl Acad Sci U S A; 1982 Jan; 79(1):183-7. PubMed ID: 6798569
[TBL] [Abstract][Full Text] [Related]
16. Preclinical characterization of a new pasteurized monoclonal antibody purified factor VIIIC.
Hrinda ME; Feldman F; Schreiber AB
Semin Hematol; 1990 Apr; 27(2 Suppl 2):19-24. PubMed ID: 2128854
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies against human factor VIII and von Willebrand factor].
Yoshioma A; Shima M
Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):681-7. PubMed ID: 3122486
[No Abstract] [Full Text] [Related]
18. The preclinical characterization of Monoclate factor VIII:C, antihemophilic factor (human).
Schreiber AB
Semin Hematol; 1988 Apr; 25(2 Suppl 1):27-32. PubMed ID: 3133774
[No Abstract] [Full Text] [Related]
19. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
Weinstein MJ; Chute LE
J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
[TBL] [Abstract][Full Text] [Related]
20. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
Ballard JO; Sanders JC; Eyster ME
Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
